Quick Answer
Corvus Pharmaceuticals, Inc. reported Shares Outstanding of 74.70 million shares for fiscal year 2025.
Corvus Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 74.70M | +10.0% |
| 2024 | 67.90M | +38.5% |
| 2023 | 49.04M | +5.3% |
| 2022 | 46.55M | +0.0% |
| 2021 | 46.55M | +64.1% |
| 2020 | 28.37M | +1.5% |
| 2019 | 27.95M | -4.7% |
| 2018 | 29.32M | +39.4% |
| 2017 | 21.04M | +0.6% |
| 2016 | 20.92M | +1361.5% |
| 2015 | 1.43M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 74.68M | +19.3% | +0.2% |
| June 30, 2025 | 74.51M | +19.1% | +9.3% |
| March 31, 2025 | 68.17M | +39.0% | +0.4% |
| December 31, 2024 | 67.90M | +38.5% | +8.5% |
| September 30, 2024 | 62.58M | +27.6% | +0.0% |
| June 30, 2024 | 62.55M | +27.9% | +27.6% |
| March 31, 2024 | 49.04M | +5.3% | +0.0% |
| December 31, 2023 | 49.04M | +5.3% | +0.0% |
- Corvus Pharmaceuticals, Inc. showed an increase of +10.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Corvus Pharmaceuticals, Inc.’s shares outstanding has grown by 5117.6% (from 1.43 million shares to 74.70 million shares).
- The most recent figure is from Corvus Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: